Is the Ramsay Health Care Limited share price a buy?

Shares in private health operator Ramsay Health Care Limited (ASX:RHC) have touched 3 month highs of $70.98 this morning as the stock continues its post AGM bullish run. Is it time to buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in private health operator Ramsay Health Care Limited (ASX: RHC) have touched 3-month highs of $70.98 this morning as the stock continues its post AGM bullish run.

Ramsay had been sold off sharply after releasing its annual result in August with its 2018 guidance failing to meet some expectations.

The market had become fearful of a further cut in its growth outlook at its AGM following a recent APRA publication that showed a reduction in private health participation. Fortunately, management reaffirmed its 2018 guidance for an 8%-10% growth in core earnings per share and the stock has rallied from the $64 level.

Ramsay is well diversified internationally with operations in Asia, Australia, France and the UK.

Australia remains the crown jewel in its portfolio and is the most profitable segment. Volume growth is expected to continue in Australia due to the ageing population and the recently announced reforms of private health insurance coverage should see a recovery in participation rates.

Ramsay intelligently adds capacity to existing hospitals and uses its scale to deliver operational efficiencies that increase margins resulting in the company outperforming competitors such as Healthscope Ltd (ASX: HSO). The company is also aggressively expanding into the pharmacy sector via its pharmacy franchise network which now boasts 55 retail pharmacies.

2017 was a difficult year for Ramsay's European operations as it battled tariff reductions with EBITDAR in France and the UK only rising 0.6% and 1.8% respectively. FY18 earnings in France and the UK are projected to be flattish but with UK tariffs scheduled to increase from April 2018, FY19 earnings should increase. The company's leverage ratio has declined to 2.2 which leaves room for acquisitions.

Foolish takeaway

2017 has been an underwhelming year for Ramsay shareholders as the company's share price has underperformed the broader market. Long term shareholders should not be overly concerned as the company's total shareholder return has averaged 23.4% over the last 10 years.

It remains well positioned to meet the growing demand of the ageing baby boomer generation and the proliferation of chronic diseases will place increased pressure on public health systems. The stock is fairly priced as it trades on 24 times forward earnings and is one to accumulate on dips to hold for the long term.

Motley Fool contributor Tim Katavic owns shares of Ramsay Health Care Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »